Antibody Drug Development Summit - Autumn 2021
View the Autumn 2021 Antibody Drug Development Summit on-demand.
The Humanized FcRn Platform: An Essential Tool for Preclinical PK Assessment of Therapeutic Antibody Candidates
Greg Christianson, Study Director, In Vivo Services, The Jackson Laboratory
speaks about the use of human FcRn transgenic mouse models to select antibody therapeutic candidates with optimum pharmacoki
Human Immune System Engrafted Mice and Their Role in Human Antibody-Based Drug Development
Brian Soper, Ph.D., Senior Manager, Technical Information Services, The Jackson Laboratory speaks about
human immune system engrafted mice and their role in human antibody-based drug development.
Testing the Efficacy of Immuno-Modulatory Antibodies in Humanized Mice
Aaron Rose, Ph.D., Senior Study Director, In Vivo Services, The Jackson Laboratory speaks about testing the efficacy of immunomodulatory antibodies in humanized mice.
A Humanized Preclinical in Vivo System to Predict the Immunotoxicity of Antibody Drug Candidates
James Keck, Ph.D., Senior Director, Innovation and Product Development, at JAX speaks about a humanized preclinical in vivo system to predict the the immunotoxicity of antibody drug candidates.